Recently, it has been reported that homozygosity for the 148M risk allele (henceforth PNPLA3 148M/M) also influences the risk of advanced fibrosis and hepatocellular carcinoma in CHC [20]–[25]. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.